NASDAQ:IDIX), Cambridge, Mass, has announced that the Swissmedic has approved telbivudine as a new treatment for chronic hepatitis B (CHB) in compensated patients with evidence of viral replication and active liver inflammation.
What does CH stand for?
CH stands for Chronic Hepatitis
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of CH
We have 75 other meanings of CH in our Acronym Attic
- Chester (postcode, United Kingdom)
- Chieti, Abruzzo (Italian province)
- Children's Hospital
- Chinchilla (rabbit breed)
- Christ's Hospital (Bluecoat School, UK)
Samples in periodicals archive:
May 15 /PRNewswire/ -- Today, the Hepatitis B Foundation and Bristol-Myers Squibb Company announced the launch of the third-annual "AIM for the B: Awareness, Involvement and Mobilization for Chronic Hepatitis B" program, a public education initiative designed to elevate awareness of chronic hepatitis B as a serious health issue in the United States and emphasize the importance of disease management, especially among Asian Americans who are disproportionately affected with the disease.
BASEL, Switzerland, January 21 /PRNewswire/ -- - First pegylated interferon to be indicated for treating chronic hepatitis B Roche announced today that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for PEGASYS(R) (peginterferon alfa-2a (40KD)) for the treatment of chronic hepatitis B.
In the other approach, based on growing evidence that the development and persistence of chronic hepatitis B infection may be caused by insufficient production of alpha interferon by white blood cells called lymphocytes, researchers use the interferon itself -- a small protein made by cells as a defense against viral infection and produced in quantity by laboratory recombinant techniques.
STOCKHOLM, Sweden -- Medivir, on behalf of the Tibotec and Medivir collaborative project, announced that this week Tibotec initiated a phase I clinical trial with a potent and selective hepatitis C virus (HCV) NS3/4A protease inhibitor, for the treatment of chronic hepatitis C virus infection.
Celgosivir is an orally administered, first-in-class alpha glucosidase 1 inhibitor, in development for the treatment of chronic hepatitis C virus (HCV) infections.
May 9 /PRNewswire/ -- In recognition of the need to increase education and awareness for chronic hepatitis B, the Hepatitis B Foundation and Bristol-Myers Squibb Company are partnering to host "AIM for the B: Awareness, Involvement and Mobilization for Chronic Hepatitis B," a public education program designed to elevate the urgency for prioritizing chronic hepatitis B as a serious health issue in the United States.
These results were achieved in chronic hepatitis C patients infected with the difficult-to-treat genotype 1 virus.